These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6538055)

  • 1. Absence of diurnal plasma prolactin rhythm in diabetic and non-diabetic uraemic patients.
    Schmitz O
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):173-8. PubMed ID: 6538055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Circadian rhythm of prolactin in patients with chronic renal failure].
    Riemel A; Grzeszczak W; Koziak H
    Przegl Lek; 1995; 52(9):440-4. PubMed ID: 8834645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance in uraemic insulin-dependent diabetics. Effect of dialysis therapy as assessed by the artificial endocrine pancreas.
    Schmitz O; Alberti KG; Orskov H
    Acta Endocrinol (Copenh); 1984 Mar; 105(3):371-8. PubMed ID: 6367331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavior of basal and stimulated serum levels of prolactin, growth hormone and gonadotropins in females with chronic uremia].
    Rudolf K; Rudolf H; Rüting M; Falkenhagen D
    Z Gesamte Inn Med; 1988 Oct; 43(19):542-4. PubMed ID: 3145648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
    Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
    Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prolactin response to acute administration of growth hormone releasing hormone in patients with uremia].
    García Martín F; Donnay Candil S; Martín Escobar E; Alvaro R; de Arriba G; Requejo R; Martín Hernández R
    Rev Clin Esp; 1989 Nov; 185(8):399-401. PubMed ID: 2516347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diurnal prolactin changes in human cerebrospinal fluid.
    Barreca T; Perria C; Franceschini R; Siani C; Messina V; Francaviglia N; Rolandi E
    Clin Endocrinol (Oxf); 1984 Jun; 20(6):649-55. PubMed ID: 6540634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Circadian profile of the prolactin concentration in the patients with end-stage renal failure].
    Niemczyk S; Matuszkiewicz-Rowińska J; Szamotulska K; Niemczyk L; Kulicki P; Ostrowski G; Zalewska-Waśniewska A; Sitkowska-Kurzec Z
    Pol Arch Med Wewn; 2006 Dec; 116(6):1137-43. PubMed ID: 18634522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired prolactin response to arginine infusion and insulin hypoglycaemia in chronic renal failure.
    Schmitz O; Møller J
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):486-91. PubMed ID: 6405570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of opiate receptor blockade with naloxone on prolactin (PRL) secretion in patients with diabetes type I (IDDM) with chronic renal failure treated with hemodialysis (HD)].
    Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Gumprecht J; Liszka M; Snit M; Gawron J
    Pol Arch Med Wewn; 1996 Aug; 96(2):132-42. PubMed ID: 9122001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetate: inhibitor of growth hormone hypersecretion in diabetic and non-diabetic uraemic subjects.
    Orskov H; Hansen AP; Hansen HE; Alberti KG; Noy GA; Nosadini R
    Acta Endocrinol (Copenh); 1982 Apr; 99(4):551-8. PubMed ID: 7072453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonpuerperal lactation and normal prolactin regulation.
    Malarkey WB
    J Clin Endocrinol Metab; 1975 Feb; 40(2):198-204. PubMed ID: 1168856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between bioactivity and immunoreactivity of serum prolactin in uraemia.
    Mooradian AD; Morley JE; Korchik WP; Ma KW; Hartfel MA; Parsons JA
    Clin Endocrinol (Oxf); 1985 Mar; 22(3):241-7. PubMed ID: 3978831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the nyctohemeral secretion of TSH and PRL in healthy euthyroid men.
    Dericks-Tan JS; Merz PG; Schrödter A; Taubert HD
    Exp Clin Endocrinol Diabetes; 1996; 104(2):145-50. PubMed ID: 8740938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered diurnal rhythm of prolactin in systemic sclerosis.
    Hilty C; Brühlmann P; Sprott H; Gay RE; Michel BA; Gay S; Neidhart M
    J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanol decreases nocturnal plasma levels of thyrotropin and growth hormone but not those of thyroid hormones or prolactin in man.
    Ekman AC; Vakkuri O; Ekman M; Leppäluoto J; Ruokonen A; Knip M
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2627-32. PubMed ID: 8675588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 24-Hour studies of prolactin and growth hormone levels in diabetic impotence.
    Maneschi F; White MC; Porta M; Kohner EM
    Horm Res; 1981; 14(2):79-86. PubMed ID: 7024082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum prolactin in uraemia: correlations between bioactivity and activity in two immunoassays.
    Smith CR; Butler J; Iggo N; Norman MR
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):295-300. PubMed ID: 2929235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered growth hormone response after growth hormone releasing hormone administration in chronic renal failure.
    Garcia RV; Andrade A; Perez J; Courel M; Casanueva FF
    J Endocrinol Invest; 1991 May; 14(5):383-9. PubMed ID: 1908493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuated pulsatile release of prolactin in men with insulin-dependent diabetes mellitus.
    Iranmanesh A; Veldhuis JD; Carlsen EC; Vaccaro VA; Booth RA; Lizarralde G; Asplin CM; Evans WS
    J Clin Endocrinol Metab; 1990 Jul; 71(1):73-8. PubMed ID: 2196281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.